ACADIA HEALTHCARE CO INC (ACHC) Fundamental Analysis & Valuation

NASDAQ:ACHC • US00404A1097

Current stock price

26.61 USD
+0.05 (+0.19%)
At close:
26.6 USD
-0.01 (-0.04%)
After Hours:

This ACHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ACHC Profitability Analysis

1.1 Basic Checks

  • ACHC had positive earnings in the past year.
  • In the past year ACHC had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
  • ACHC had a positive operating cash flow in each of the past 5 years.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • ACHC has a worse Return On Assets (-19.95%) than 78.00% of its industry peers.
  • ACHC has a Return On Equity of -56.58%. This is in the lower half of the industry: ACHC underperforms 72.00% of its industry peers.
  • ACHC has a Return On Invested Capital of 6.00%. This is in the better half of the industry: ACHC outperforms 62.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACHC is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROIC 6%
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • With an excellent Operating Margin value of 11.71%, ACHC belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
  • ACHC's Operating Margin has declined in the last couple of years.
  • ACHC does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 11.71%
PM (TTM) N/A
GM N/A
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

2

2. ACHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
  • ACHC has less shares outstanding than it did 1 year ago.
  • ACHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ACHC has a worse debt to assets ratio.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.11, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
  • ACHC has a worse Altman-Z score (1.11) than 67.00% of its industry peers.
  • ACHC has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ACHC (1.27) is worse than 67.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACC0.73
WACC8.27%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • ACHC has a Current Ratio of 1.55. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.55, ACHC perfoms like the industry average, outperforming 59.00% of the companies in the same industry.
  • A Quick Ratio of 1.54 indicates that ACHC should not have too much problems paying its short term obligations.
  • ACHC has a Quick ratio of 1.54. This is in the better half of the industry: ACHC outperforms 63.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. ACHC Growth Analysis

3.1 Past

  • ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.79%.
  • ACHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.12% yearly.
  • Looking at the last year, ACHC shows a small growth in Revenue. The Revenue has grown by 5.04% in the last year.
  • Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%

3.2 Future

  • ACHC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.96% yearly.
  • ACHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.26% yearly.
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. ACHC Valuation Analysis

4.1 Price/Earnings Ratio

  • ACHC is valuated correctly with a Price/Earnings ratio of 13.17.
  • 86.00% of the companies in the same industry are more expensive than ACHC, based on the Price/Earnings ratio.
  • ACHC is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.55 indicates a rather expensive valuation of ACHC.
  • 67.00% of the companies in the same industry are more expensive than ACHC, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.20, ACHC is valued rather cheaply.
Industry RankSector Rank
PE 13.17
Fwd PE 17.55
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ACHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACHC is cheaper than 78.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.36
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as ACHC's earnings are expected to decrease with -2.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%

0

5. ACHC Dividend Analysis

5.1 Amount

  • No dividends for ACHC!.
Industry RankSector Rank
Dividend Yield 0%

ACHC Fundamentals: All Metrics, Ratios and Statistics

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (4/15/2026, 8:00:00 PM)

After market: 26.6 -0.01 (-0.04%)

26.61

+0.05 (+0.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners133.55%
Inst Owner Change0.01%
Ins Owners0.96%
Ins Owner Change1.51%
Market Cap2.45B
Revenue(TTM)3.31B
Net Income(TTM)-1.10B
Analysts74
Price Target23.46 (-11.84%)
Short Float %24.33%
Short Ratio6.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.79%
Min EPS beat(2)5.25%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)12.66%
Min EPS beat(4)5.25%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)5.22%
EPS beat(12)10
Avg EPS beat(12)4.68%
EPS beat(16)13
Avg EPS beat(16)10.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)20.15%
PT rev (3m)8.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.25%
EPS NY rev (1m)0.94%
EPS NY rev (3m)-26.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.19%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 13.17
Fwd PE 17.55
P/S 0.74
P/FCF N/A
P/OCF 18.57
P/B 1.26
P/tB 4.4
EV/EBITDA 8.36
EPS(TTM)2.02
EY7.59%
EPS(NY)1.52
Fwd EY5.7%
FCF(TTM)-4.78
FCFYN/A
OCF(TTM)1.43
OCFY5.39%
SpS36
BVpS21.18
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.0244 (16.59%)
Profitability
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROCE 7.76%
ROIC 6%
ROICexc 6.16%
ROICexgc 8.63%
OM 11.71%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ROICexc(3y)7.58%
ROICexc(5y)7.53%
ROICexgc(3y)13.72%
ROICexgc(5y)14.49%
ROCE(3y)9.6%
ROCE(5y)9.52%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-7.02%
ROICexc growth 5Y2.87%
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 302.15%
Cap/Sales 17.26%
Interest Coverage 3.11
Cash Conversion 22.85%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 1.11
F-Score5
WACC8.27%
ROIC/WACC0.73
Cap/Depr(3y)361.37%
Cap/Depr(5y)312.98%
Cap/Sales(3y)17.88%
Cap/Sales(5y)15.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%
EBIT growth 1Y-25.72%
EBIT growth 3Y-4.55%
EBIT growth 5Y3.12%
EBIT Next Year46.21%
EBIT Next 3Y18%
EBIT Next 5Y20.08%
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.7%
OCF growth 3Y-29.76%
OCF growth 5Y-25.73%

ACADIA HEALTHCARE CO INC / ACHC Fundamental Analysis FAQ

What is the fundamental rating for ACHC stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACHC.


What is the valuation status for ACHC stock?

ChartMill assigns a valuation rating of 4 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.


What is the profitability of ACHC stock?

ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 3 / 10.


What is the valuation of ACADIA HEALTHCARE CO INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ACADIA HEALTHCARE CO INC (ACHC) is 13.17 and the Price/Book (PB) ratio is 1.26.


What is the financial health of ACADIA HEALTHCARE CO INC (ACHC) stock?

The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.